These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7506653)

  • 1. Miocamycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.
    Holliday SM; Faulds D
    Drugs; 1993 Oct; 46(4):720-45. PubMed ID: 7506653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.
    Peters DH; Friedel HA; McTavish D
    Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.
    Peters DH; Clissold SP
    Drugs; 1992 Jul; 44(1):117-64. PubMed ID: 1379907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activity of rokitamycin compared with that of other macrolides.
    Yu KW; Briones F; Chin NX; Neu HC
    Diagn Microbiol Infect Dis; 1991; 14(4):331-5. PubMed ID: 1889182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients.
    Langtry HD; Brogden RN
    Drugs; 1997 Jun; 53(6):973-1004. PubMed ID: 9179528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis.
    Kilic D; Basar MM; Kaygusuz S; Yilmaz E; Basar H; Batislam E
    Jpn J Infect Dis; 2004 Feb; 57(1):17-20. PubMed ID: 14985631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide antibiotics in paediatric infectious diseases.
    Guay DR
    Drugs; 1996 Apr; 51(4):515-36. PubMed ID: 8706592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14- and 15-membered ring macrolides.
    Braga PC
    J Chemother; 2002 Apr; 14(2):115-31. PubMed ID: 12017366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of miocamycin in the therapy of non-specific genital infections (NSGI): non-gonococcal urethritis (NGU) and acute urethral syndrome (AUS).
    Furneri PM; Roccasalva L; Fallica L; Tempera G
    Int J Clin Pharmacol Res; 1988; 8(2):111-6. PubMed ID: 3259948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use.
    Markham A; Faulds D
    Drugs; 1994 Aug; 48(2):297-326. PubMed ID: 7527329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic data and therapeutic efficacy of miocamycin: serum, urinary and prostatic levels. Therapeutic aspects in acute urethral syndrome and non-gonococcal urethritis.
    Furneri PM; Roccasalva L; Fallica L; Tempera G
    J Chemother; 1989 Jul; 1(4 Suppl):581-2. PubMed ID: 16312542
    [No Abstract]   [Full Text] [Related]  

  • 12. [Microbiological, pharmacokinetic and clinical studies of rokitamycin dry syrup in the pediatric field].
    Motohiro T; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Fujimoto T; Sakata Y; Yamashita F; Suzuki K
    Jpn J Antibiot; 1988 Jul; 41(7):920-59. PubMed ID: 3050186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility of Haemophilus influenzae strains isolated from the urethra of men with acute urethritis and/or epididymitis.
    Deguchi T; Ito S; Hatazaki K; Horie K; Yasuda M; Nakane K; Mizutani K; Tsuchiya T; Yokoi S; Hanaoka N; Shimuta K; Ohnishi M; Muratani T; Nakano M
    J Infect Chemother; 2017 Nov; 23(11):804-807. PubMed ID: 28619239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiological profile of telithromycin, the first ketolide antimicrobial.
    Felmingham D
    Clin Microbiol Infect; 2001; 7 Suppl 3():2-10. PubMed ID: 11523558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rokitamycin in the treatment of female genital Chlamydia and Mycoplasma infections. Comparative study vs josamycin ].
    Colombo U; Pifarotti G; Amidani M; Viezzoli T; Pifarotti P
    Minerva Ginecol; 1998 Nov; 50(11):491-7. PubMed ID: 9882991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections.
    Balfour JA; Lamb HM
    Drugs; 2000 Jan; 59(1):115-39. PubMed ID: 10718103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections.
    Dunn CJ; Barradell LB
    Drugs; 1996 Mar; 51(3):483-505. PubMed ID: 8882383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
    Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
    Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clarithromycin and azithromycin: new macrolide antibiotics.
    Piscitelli SC; Danziger LH; Rodvold KA
    Clin Pharm; 1992 Feb; 11(2):137-52. PubMed ID: 1312921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azithromycin. A review of its use in paediatric infectious diseases.
    Langtry HD; Balfour JA
    Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.